
Diabetes drugmaker Structure Therapeutics stock soars 73% in market debut
ismagilov/iStock via Getty Images Structure Therapeutics (NASDAQ:GPCR) stock soared 73% Friday after the diabetes drug developer raised $161M through an upsized US initial public offering.